Figure 1From: Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial Treatment and follow-up schedule. Follow up begins after the completion of the first treatment. For determination of progression-free survival (PFS) only the magnetic resonance imaging (MRI) performed at 3, 6, 9Â months et cetera, will be used in both groups.Back to article page